Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.9 USD | -2.12% | +5.64% | -4.33% |
30/04 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
30/04 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.33% | 1.75B | |
+31.52% | 690B | |
+24.81% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.08% | 235B | |
+5.30% | 199B | |
-10.02% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences to Conduct Phase 3 Trial of Pitolisant for Treatment of Idiopathic Hypersomnia